> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Immodulon Therapeutics
- URL: https://www.whiteroseintelligence.com/immodulon-therapeutics/
- Published: 1999-01-02T18:02:00.000Z
- Updated: 2025-01-02T23:04:46.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**Immodulon Therapeutics** is a British biotechnology company based in Uxbridge, England.

## COVID-19

Immodulon participated in the COV-IMMUNO clinical trial to evaluate IMM-101 for its use as a [COVID-19 vaccine](https://www.whiteroseintelligence.com/COVID-19-vaccine).[\[1\]](#fn1)

## Organization

Immodulon is an industry partner of BioCanRx.[\[2\]](#fn2)

## External links

- [Website](https://www.immodulon.com/)

---

1. Canadian Cancer Trials Group. (2023, January 31). *Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure.* ClinicalTrials.gov. <https://web.archive.org/web/20230710183029mp%5F/https://classic.clinicaltrials.gov/ct2/show/NCT04442048> [↩︎](#fnref1)
2. *Our Partners & Collaborators.* BioCanRx. Retrieved September 27, 2022, from <http://archive.today/2022.09.28-044532/https://biocanrx.com/partnerships/our-partners%23> [↩︎](#fnref2)